DERMATA THERAPEUTICS, INC.

DRMA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
DEFA14A Jun 2, 2025 DEFA14A
DEF 14A Jun 2, 2025 DEF 14A
PRE 14A May 23, 2025 PRE 14A
8-K May 21, 2025 8-K
8-K May 16, 2025 8-K
SCHEDULE 13G/A May 15, 2025
8-K May 14, 2025 8-K
10-Q May 14, 2025 10-Q
SCHEDULE 13G/A May 9, 2025
EFFECT Apr 23, 2025
424B3 Apr 23, 2025
CORRESP Apr 21, 2025
UPLOAD Apr 21, 2025
S-3 Apr 15, 2025 FORM S-3
8-K Apr 15, 2025 FORM 8-K
SCHEDULE 13D/A Apr 7, 2025
SCHEDULE 13D/A Apr 3, 2025
8-K Mar 28, 2025 FORM 8-K
8-K Mar 27, 2025 FORM 8-K
8-K Mar 25, 2025 FORM 8-K
8-K Mar 17, 2025 FORM 8-K
10-K Mar 17, 2025 FORM 10-K
SCHEDULE 13G/A Feb 14, 2025
SCHEDULE 13D/A Feb 13, 2025
EFFECT Feb 5, 2025
← Newer Page 4 of 15 · 366 filings Older →